There will be a Rheumatology seminar scheduled for Wednesday, April 12 in the Goldman International Conference Room at the Feinstein Institute for Medical Research. Our guest speaker will be Gregg Silverman, MD, professor of Medicine and Pathology and associate director in the Division of Rheumatology at the New York University School of Medicine. Dr. Silverman will be presenting “Lupus and the Microbiome.”
LEARNING OBJECTIVES: Upon completion of this session, participants should be able to:
Target Audience: Fellows. Faculty and Community Adult Rheumatologists, Faculty Pediatric Rheumatologists, Medical Residents, Pediatric Residents, Adult Rheumatology trainees and Pediatric Rheumatology trainees, Nurses, Allied Health Professionals, PhD candidates, Post-Doctoral Fellows.
CME ACCREDITATION: Northwell Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION: Northwell Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit. Each physician should only claim credit commensurate with the extent of their participation in the activity.
DISCLOSURE POLICY: Northwell Health adheres to the ACCME’s Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with commercial interests. All relevant conflicts of interest will be resolved prior to the commencement of the activity.
Planner and Speaker’s Disclosures: Gregg Silverman, MD has nothing to disclose. Diane Horowitz, MD, as RSS Course Director, has nothing to disclose. Elena Katzap, DO, Julie Schwartzman-Morris, MD, Galina Marder, MD, and Sonali Narain, MD have nothing to disclose. Anne Davidson, MD, receives consulting fees from Celgene; Richard Furie, MD receives research support from AstraZeneca, BiogenIdec, BMS, Boehringer-Ingelheim, Celgene, Eli Lilly, GlaxoSmithKline, Mallinckrodt Pharmaceuticals, MedImmune, Pfizer, Sanofi, and UCB for his role as a consultant and investigator; receives consulting fees from Baxalta, EMD Merck, and Estrela (Janssen) for his role as consultant; receives research support from Takeda for his role as investigator.
Recognition of Program Support: An announcement of program support will be made to all attendees at the beginning of each Regularly Scheduled Session.